Ned Pojskic is Green Shield Canada’s Leader for Pharmacy and Health Provider Relations. In this role, he is responsible for setting GSC’s strategic direction with respect to provider and drug benefits management. He takes the lead in managing stakeholder relations with all health care providers, including pharmacy, dental, and paramedical. Ned is also responsible for overall drug formulary management, including pricing and policy as well as pharmaceutical industry partnerships.
With an industry background that includes a role as Director of Health Policy for the Ontario Pharmacists Association, Ned is a key member of GSC’s Strategic Market Solutions Team. Ned holds Masters and PhD degrees from the Department of Pharmaceutical Sciences at the University of Toronto and is currently appointed as an adjunct professor within the Leslie Dan Faculty of Pharmacy.
Agenda: Day 1 Oct 6, 2020
Panel Discussion: THE ROAD TO ADVANCED THERAPEUTICS
Assessing the State of Play: Are Gene Therapies the Next Big Game Changer?
Although still considered by some an experimental technique, gene therapy, which focuses on the genetic modification of cells, is poised to become much more prevalent. Researchers are constantly unveiling new approaches to gene therapy. Inform your development pipeline with an in-depth understanding of these strategies, including:
- Replacing a mutated disease-causing gene with a healthy copy of the gene
- Inactivating, or “knocking out,” a mutated gene that is functioning improperly
- Introducing a new gene into the body to help fight a disease
Equip your team with actionable insights in your development of efficacious gene therapy products
Agenda: Day 2 Oct 7, 2020